Bone Status in Obese, Non-diabetic, Antipsychotic-Treated Patients, and Effects of the Glucagon-Like Peptide-1 Receptor Agonist Exenatide on Bone Turnover Markers and Bone Mineral...

by Robert Eriksson, Robert Eriksson, Brian V. Broberg, Pelle L. Ishøy, Nikolaj Bak, Ulrik B. Andersen, Niklas R. Jørgensen, Niklas R. Jørgensen, Filip K. Knop, Filip K. Knop, Filip K. Knop, Bjørn H. Ebdrup, Bjørn H. Ebdrup, Bjørn H. Ebdrup
Published 2019-01-01

The impact of exercise training complementary to early intervention in patients with first-episode psychosis: a qualitative sub-study from a randomized controlled feasibility trial

by Lene Q. Larsen, Helle Schnor, Britt P. Tersbøl, Bjørn H. Ebdrup, Nikolai B. Nordsborg, Julie Midtgaard
Published 2019-06-01

The impact of schizophrenia and intelligence on the relationship between age and brain volume

by Maria H. Jensen, Nikolaj Bak, Egill Rostrup, Mette Ø. Nielsen, Christos Pantelis, Birte Y. Glenthøj, Bjørn H. Ebdrup, Birgitte Fagerlund
Published 2019-03-01

No Effects of Cognitive Remediation on Cerebral White Matter in Individuals at Ultra-High Risk for Psychosis—A Randomized Clinical Trial

by Tina D. Kristensen, Tina D. Kristensen, Bjørn H. Ebdrup, Bjørn H. Ebdrup, Bjørn H. Ebdrup, Carsten Hjorthøj, Carsten Hjorthøj, René C. W. Mandl, René C. W. Mandl, Jayachandra M. Raghava, Jayachandra M. Raghava, Jens Richardt M. Jepsen, Jens Richardt M. Jepsen, Birgitte Fagerlund, Birgitte Fagerlund, Louise B. Glenthøj, Louise B. Glenthøj, Christina Wenneberg, Christina Wenneberg, Kristine Krakauer, Christos Pantelis, Christos Pantelis, Birte Y. Glenthøj, Birte Y. Glenthøj, Merete Nordentoft, Merete Nordentoft, Merete Nordentoft
Published 2020-08-01

Identification of a Serotonin 2A Receptor Subtype of Schizophrenia Spectrum Disorders With Pimavanserin: The Sub-Sero Proof-of-Concept Trial Protocol

by Olga B. Baltzersen, Herbert Y. Meltzer, Vibe G. Frokjaer, Vibe G. Frokjaer, Jayachandra M. Raghava, Jayachandra M. Raghava, Lone Baandrup, Lone Baandrup, Birgitte Fagerlund, Henrik B.W. Larsson, H. Christian Fibiger, Birte Y. Glenthøj, Birte Y. Glenthøj, Gitte M. Knudsen, Gitte M. Knudsen, Bjørn H. Ebdrup, Bjørn H. Ebdrup
Published 2020-04-01

Exercise training complementary to specialised early intervention in patients with first-episode psychosis: a feasibility randomised trial

by Julie Midtgaard, Helle Schnor, Eik D. Bjerre, Tobias Jespersen, Nina Jelsøe, Nanna Frølund, Søren Seier, Jacob W. Rønbøg, Nikolai B. Nordsborg, Bjørn H. Ebdrup
Published 2021-08-01

TAILOR – tapered discontinuation versus maintenance therapy of antipsychotic medication in patients with newly diagnosed schizophrenia or persistent delusional disorder in remissio...

by Anne Emilie Stürup, Heidi Dorthe Jensen, Signe Dolmer, Merete Birk, Nikolai Albert, Mai Nielsen, Carsten Hjorthøj, Lene Eplov, Bjørn H. Ebdrup, Ole Mors, Merete Nordentoft
Published 2017-09-01

Striatal Volume Increase After Six Weeks of Selective Dopamine D2/3 Receptor Blockade in First-Episode, Antipsychotic-Naïve Schizophrenia Patients

by Helle G. Andersen, Helle G. Andersen, Jayachandra M. Raghava, Jayachandra M. Raghava, Claus Svarer, Sanne Wulff, Louise B. Johansen, Patrick K. Antonsen, Patrick K. Antonsen, Mette Ø. Nielsen, Mette Ø. Nielsen, Egill Rostrup, Anthony C. Vernon, Anthony C. Vernon, Lars T. Jensen, Lars H. Pinborg, Birte Y. Glenthøj, Birte Y. Glenthøj, Bjørn H. Ebdrup, Bjørn H. Ebdrup
Published 2020-05-01